A year after treatment finished, doctors found the cancer had spread to Sonny Sweetman’s liver. But he received a new treatment for the Stage 4 cancer.
Minimally invasive approach gives a better treatment option to patients with metastatic uveal melanoma who have liver metastases that cannot be surgically removed.
The FDA has approved HEPZATO Kit for treating ocular melanoma that has metastasized to the liver, marking a significant breakthrough in targeted cancer therapy developed by Delcath Systems, Inc.
